| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.75B | 159.54B | 156.81B | 137.69B | 115.94B | 113.66B |
| Gross Profit | 23.39B | 22.77B | 23.30B | 14.80B | 15.26B | 15.49B |
| EBITDA | 12.25B | 10.29B | 13.83B | 8.58B | 8.81B | 8.83B |
| Net Income | 1.24B | 737.00M | 4.22B | -907.00M | 1.01B | 3.63B |
Balance Sheet | ||||||
| Total Assets | 129.98B | 117.14B | 111.25B | 97.28B | 96.44B | 86.86B |
| Cash, Cash Equivalents and Short-Term Investments | 16.94B | 22.69B | 17.65B | 12.84B | 13.40B | 14.42B |
| Total Debt | 46.63B | 39.67B | 33.01B | 28.66B | 28.68B | 26.02B |
| Total Liabilities | 80.75B | 69.05B | 62.96B | 57.37B | 54.75B | 51.38B |
| Stockholders Equity | 45.62B | 44.27B | 44.68B | 36.53B | 38.64B | 32.72B |
Cash Flow | ||||||
| Free Cash Flow | -7.59B | -951.00M | 2.55B | -575.00M | -2.23B | 4.43B |
| Operating Cash Flow | 2.73B | 8.48B | 10.14B | 5.68B | 3.34B | 7.89B |
| Investing Cash Flow | -12.19B | -8.12B | -7.14B | -4.45B | -5.65B | -260.00M |
| Financing Cash Flow | 9.37B | 4.09B | 743.00M | -2.91B | 813.00M | -8.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥144.39B | 16.04 | ― | 5.78% | -4.26% | 17.85% | |
70 Outperform | ¥6.52B | 5.89 | ― | 2.64% | 2.28% | 41.72% | |
66 Neutral | ¥48.80B | 4.93 | ― | 0.55% | 7.65% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥3.74B | 10.35 | ― | 3.03% | 4.17% | -693.96% | |
59 Neutral | ¥41.33B | 50.47 | ― | 5.35% | -6.20% | -64.65% | |
47 Neutral | ¥25.36B | -5.63 | ― | 3.33% | -3.91% | -36.53% |